title: Giant cell hepatitis and autoimmune hemolytic anemia successfully treated with rituximab.
authors: Recanati Transplant Institute, Mt. Sinai School of Medicine, New York, NY 10029, USA. tamir.miloh@mssm.edu
authors: Tamir
authors: T
authors: Miloh
authors: Deepa
authors: D
authors: Manwani
authors: Raffaella
authors: R
authors: Morotti
authors: Emre
authors: E
authors: Sukru
authors: Benjamin
authors: B
authors: Shneider
authors: Nanda
authors: N
authors: Kerkar
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000453:epidemiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D015897:Comorbidity; D015726:Giant Cells; D006505:Hepatitis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab